Filing Details
- Accession Number:
- 0001178913-18-002611
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-02 17:20:16
- Reporting Period:
- 2018-10-01
- Accepted Time:
- 2018-10-02 17:20:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1606645 | Foamix Pharmaceuticals Ltd. | FOMX | Medicinal Chemicals & Botanical Products (2833) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1727807 | P. Russell Elliott | C/O Foamix Pharmaceuticals Ltd. 2 Holtzman Street Rehovot L3 7670402 | Vp Drug Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2018-10-01 | 142 | $5.81 | 12,442 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of restricted share units. This sale is mandated by the Issuer's non-discretionary policy that requires the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Billionaire Hedge Funds
